
Gary Jackson
Supervisory Patent Examiner (ID: 5661, Phone: (571)272-4697 , Office: P/3769 )
| Most Active Art Unit | 3731 |
| Art Unit(s) | 3304, 3308, 4158, 3727, 3309, 2899, 3734, 3792, 3731, 3407, 3769 |
| Total Applications | 2094 |
| Issued Applications | 1632 |
| Pending Applications | 166 |
| Abandoned Applications | 295 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 393409
[patent_doc_number] => 07297099
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-11-20
[patent_title] => 'Use of osteopontin for the treatment and/or prevention of neurologic diseases'
[patent_app_type] => utility
[patent_app_number] => 10/981737
[patent_app_country] => US
[patent_app_date] => 2004-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 29
[patent_no_of_words] => 34967
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/297/07297099.pdf
[firstpage_image] =>[orig_patent_app_number] => 10981737
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/981737 | Use of osteopontin for the treatment and/or prevention of neurologic diseases | Nov 4, 2004 | Issued |
Array
(
[id] => 270375
[patent_doc_number] => 07563611
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-07-21
[patent_title] => 'Recombinant microorganism'
[patent_app_type] => utility
[patent_app_number] => 10/578615
[patent_app_country] => US
[patent_app_date] => 2004-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4629
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/563/07563611.pdf
[firstpage_image] =>[orig_patent_app_number] => 10578615
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/578615 | Recombinant microorganism | Nov 4, 2004 | Issued |
Array
(
[id] => 910319
[patent_doc_number] => 07329641
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-02-12
[patent_title] => 'Blood substitutes'
[patent_app_type] => utility
[patent_app_number] => 10/979483
[patent_app_country] => US
[patent_app_date] => 2004-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 9728
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/329/07329641.pdf
[firstpage_image] =>[orig_patent_app_number] => 10979483
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/979483 | Blood substitutes | Oct 31, 2004 | Issued |
Array
(
[id] => 587840
[patent_doc_number] => 07439221
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-10-21
[patent_title] => 'Methods and compositions for modulating gamete adhesion'
[patent_app_type] => utility
[patent_app_number] => 10/575816
[patent_app_country] => US
[patent_app_date] => 2004-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 20639
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/439/07439221.pdf
[firstpage_image] =>[orig_patent_app_number] => 10575816
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/575816 | Methods and compositions for modulating gamete adhesion | Oct 17, 2004 | Issued |
Array
(
[id] => 7169387
[patent_doc_number] => 20050202403
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-15
[patent_title] => 'Yeast cells expressing modified G proteins and methods of use therefor'
[patent_app_type] => utility
[patent_app_number] => 10/967087
[patent_app_country] => US
[patent_app_date] => 2004-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 33891
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0202/20050202403.pdf
[firstpage_image] =>[orig_patent_app_number] => 10967087
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/967087 | Yeast cells expressing modified G proteins and methods of use therefor | Oct 14, 2004 | Issued |
Array
(
[id] => 111456
[patent_doc_number] => 07718399
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-05-18
[patent_title] => 'Expression vector for secreting antibody fragment using E. coli signal sequence and method for mass-producing antibody fragment'
[patent_app_type] => utility
[patent_app_number] => 10/576068
[patent_app_country] => US
[patent_app_date] => 2004-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 10
[patent_no_of_words] => 9716
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/718/07718399.pdf
[firstpage_image] =>[orig_patent_app_number] => 10576068
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/576068 | Expression vector for secreting antibody fragment using E. coli signal sequence and method for mass-producing antibody fragment | Oct 13, 2004 | Issued |
Array
(
[id] => 7083243
[patent_doc_number] => 20050048623
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-03
[patent_title] => 'Cell cycle and proliferation proteins'
[patent_app_type] => utility
[patent_app_number] => 10/959539
[patent_app_country] => US
[patent_app_date] => 2004-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35344
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20050048623.pdf
[firstpage_image] =>[orig_patent_app_number] => 10959539
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/959539 | Cell cycle and proliferation proteins | Oct 5, 2004 | Abandoned |
Array
(
[id] => 7018867
[patent_doc_number] => 20050220886
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-06
[patent_title] => 'Modulators of the Notch signalling pathway and uses thereof in medical treatment'
[patent_app_type] => utility
[patent_app_number] => 10/958784
[patent_app_country] => US
[patent_app_date] => 2004-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 36
[patent_no_of_words] => 42417
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20050220886.pdf
[firstpage_image] =>[orig_patent_app_number] => 10958784
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/958784 | Modulators of the Notch signalling pathway and uses thereof in medical treatment | Oct 4, 2004 | Abandoned |
Array
(
[id] => 314840
[patent_doc_number] => 07524810
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2009-04-28
[patent_title] => 'Modified Cry34 proteins'
[patent_app_type] => utility
[patent_app_number] => 10/956725
[patent_app_country] => US
[patent_app_date] => 2004-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 4987
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/524/07524810.pdf
[firstpage_image] =>[orig_patent_app_number] => 10956725
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/956725 | Modified Cry34 proteins | Sep 30, 2004 | Issued |
Array
(
[id] => 5005488
[patent_doc_number] => 20070203059
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-30
[patent_title] => 'Targeted Drug-Formaldehyde Conjugates And Methods Of Making And Using The Same'
[patent_app_type] => utility
[patent_app_number] => 10/573280
[patent_app_country] => US
[patent_app_date] => 2004-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 11280
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20070203059.pdf
[firstpage_image] =>[orig_patent_app_number] => 10573280
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/573280 | Targeted Drug-Formaldehyde Conjugates And Methods Of Making And Using The Same | Sep 19, 2004 | Abandoned |
Array
(
[id] => 5056873
[patent_doc_number] => 20070059795
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-15
[patent_title] => 'Engineered zinc finger proteins for regulation of gene expression'
[patent_app_type] => utility
[patent_app_number] => 10/572886
[patent_app_country] => US
[patent_app_date] => 2004-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 32631
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20070059795.pdf
[firstpage_image] =>[orig_patent_app_number] => 10572886
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/572886 | Engineered zinc finger proteins for regulation of gene expression | Sep 16, 2004 | Issued |
Array
(
[id] => 7074767
[patent_doc_number] => 20050148035
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-07
[patent_title] => 'IGF binding proteins'
[patent_app_type] => utility
[patent_app_number] => 10/936059
[patent_app_country] => US
[patent_app_date] => 2004-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 18015
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20050148035.pdf
[firstpage_image] =>[orig_patent_app_number] => 10936059
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/936059 | IGF binding proteins | Sep 7, 2004 | Issued |
Array
(
[id] => 5085326
[patent_doc_number] => 20070275377
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-29
[patent_title] => 'Isolated Photoprotein mtClytin, and Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 10/572175
[patent_app_country] => US
[patent_app_date] => 2004-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 8216
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20070275377.pdf
[firstpage_image] =>[orig_patent_app_number] => 10572175
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/572175 | Isolated photoprotein mtClytin, and use thereof | Sep 2, 2004 | Issued |
Array
(
[id] => 393823
[patent_doc_number] => 07297516
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-11-20
[patent_title] => 'Recombinant peptide'
[patent_app_type] => utility
[patent_app_number] => 10/934009
[patent_app_country] => US
[patent_app_date] => 2004-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 11510
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 154
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/297/07297516.pdf
[firstpage_image] =>[orig_patent_app_number] => 10934009
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/934009 | Recombinant peptide | Sep 2, 2004 | Issued |
Array
(
[id] => 307254
[patent_doc_number] => 07531320
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-05-12
[patent_title] => 'Modulation of β-catenin/TCF-activated transcription'
[patent_app_type] => utility
[patent_app_number] => 10/928626
[patent_app_country] => US
[patent_app_date] => 2004-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 30
[patent_no_of_words] => 33898
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/531/07531320.pdf
[firstpage_image] =>[orig_patent_app_number] => 10928626
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/928626 | Modulation of β-catenin/TCF-activated transcription | Aug 26, 2004 | Issued |
Array
(
[id] => 7098462
[patent_doc_number] => 20050130921
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-16
[patent_title] => 'Vibrionaceae replication factors and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 10/922792
[patent_app_country] => US
[patent_app_date] => 2004-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 10893
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20050130921.pdf
[firstpage_image] =>[orig_patent_app_number] => 10922792
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/922792 | Vibrionaceae replication factors and methods of use thereof | Aug 19, 2004 | Issued |
Array
(
[id] => 5590897
[patent_doc_number] => 20060040349
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-23
[patent_title] => 'Thermophilic hydrophobin proteins and applications for surface modification'
[patent_app_type] => utility
[patent_app_number] => 10/920876
[patent_app_country] => US
[patent_app_date] => 2004-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 13270
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0040/20060040349.pdf
[firstpage_image] =>[orig_patent_app_number] => 10920876
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/920876 | Thermophilic hydrophobin proteins and applications for surface modification | Aug 17, 2004 | Issued |
Array
(
[id] => 170749
[patent_doc_number] => 07662774
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-02-16
[patent_title] => 'Method for using lipoprotein associated coagulation inhibitor to treat sepsis'
[patent_app_type] => utility
[patent_app_number] => 10/891493
[patent_app_country] => US
[patent_app_date] => 2004-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 14
[patent_no_of_words] => 20458
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/662/07662774.pdf
[firstpage_image] =>[orig_patent_app_number] => 10891493
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/891493 | Method for using lipoprotein associated coagulation inhibitor to treat sepsis | Jul 14, 2004 | Issued |
Array
(
[id] => 7218097
[patent_doc_number] => 20050054830
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-10
[patent_title] => 'Methods and apparatus for spinning spider silk protein'
[patent_app_type] => utility
[patent_app_number] => 10/893588
[patent_app_country] => US
[patent_app_date] => 2004-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 18788
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20050054830.pdf
[firstpage_image] =>[orig_patent_app_number] => 10893588
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/893588 | Methods and apparatus for spinning spider silk protein | Jul 11, 2004 | Abandoned |
Array
(
[id] => 612642
[patent_doc_number] => 07148039
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-12-12
[patent_title] => 'Cosmetic or dermatological composition contacting at least one natural or recombinant spider silk or an analog'
[patent_app_type] => utility
[patent_app_number] => 10/887100
[patent_app_country] => US
[patent_app_date] => 2004-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 11
[patent_no_of_words] => 5076
[patent_no_of_claims] => 94
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/148/07148039.pdf
[firstpage_image] =>[orig_patent_app_number] => 10887100
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/887100 | Cosmetic or dermatological composition contacting at least one natural or recombinant spider silk or an analog | Jul 8, 2004 | Issued |